In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci

Seong Geun Hong; Ellen Smith Moland; Paul A. Wickman; Jennifer A. Black; Ashfaque Hossain; Nancy D. Hanson; Kenneth S. Thomson

doi:10.1128/AAC.00959-06

In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci

Seong Geun Hong, Ellen Smith Moland, Paul A. Wickman, Jennifer A. Black, Ashfaque Hossain, Nancy D. Hanson, Kenneth S. Thomson

Department of Medical Microbiology and Immunology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.

Original language	English (US)
Pages (from-to)	1512-1514
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	51
Issue number	4
DOIs	https://doi.org/10.1128/AAC.00959-06
State	Published - Apr 2007

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.00959-06

Fingerprint Dive into the research topics of 'In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci'. Together they form a unique fingerprint.

Cite this

In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci. / Hong, Seong Geun; Moland, Ellen Smith; Wickman, Paul A.; Black, Jennifer A.; Hossain, Ashfaque; Hanson, Nancy D.; Thomson, Kenneth S.

In: Antimicrobial agents and chemotherapy, Vol. 51, No. 4, 04.2007, p. 1512-1514.

Research output: Contribution to journal › Article › peer-review

@article{c0a6fa68c2ea4437a47ce830264c69c1,

title = "In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci",

abstract = "DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.",

author = "Hong, {Seong Geun} and Moland, {Ellen Smith} and Wickman, {Paul A.} and Black, {Jennifer A.} and Ashfaque Hossain and Hanson, {Nancy D.} and Thomson, {Kenneth S.}",

year = "2007",

month = apr,

doi = "10.1128/AAC.00959-06",

language = "English (US)",

volume = "51",

pages = "1512--1514",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci

AU - Hong, Seong Geun

AU - Moland, Ellen Smith

AU - Wickman, Paul A.

AU - Black, Jennifer A.

AU - Hossain, Ashfaque

AU - Hanson, Nancy D.

AU - Thomson, Kenneth S.

PY - 2007/4

Y1 - 2007/4

N2 - DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.

AB - DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.

UR - http://www.scopus.com/inward/record.url?scp=34247141317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247141317&partnerID=8YFLogxK

U2 - 10.1128/AAC.00959-06

DO - 10.1128/AAC.00959-06

M3 - Article

C2 - 17220419

AN - SCOPUS:34247141317

VL - 51

SP - 1512

EP - 1514

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -